Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium.

Abstract:

:The Lunenburg Lymphoma Biomarker Consortium (LLBC) evaluated the prognostic value of IHC biomarkers in a large series of patients with diffuse large B-cell lymphoma (DLBCL). Clinical data and tumor samples were retrieved from 12 studies from Europe and North America, with patients treated before or after the rituximab era. Using tissue microarrays from 1514 patients, IHC for BCL2, BCL6, CD5, CD10, MUM1, Ki67, and HLA-DR was performed and scored according to previously validated protocols. Optimal cut points predicting overall survival of patients treated in the rituximab era could only be determined for CD5 (P = .003) and Ki67 (P = .02), whereas such cut points for BCL2, BCL6, HLA-DR, and MUM1 could only be defined in patients not receiving rituximab. A prognostic model for patients treated in the rituximab era identified 4 risk groups using BCL2, Ki67, and International Prognostic Index (IPI) with improved discrimination of low-risk patients. Newly recognized correlations between specific biomarkers and IPI highlight the importance of carefully controlling for clinical and biologic factors in prognostic models. These data demonstrate that the IPI remains the best available index in patients with DLBCL treated with rituximab and chemotherapy.

journal_name

Blood

journal_title

Blood

authors

Salles G,de Jong D,Xie W,Rosenwald A,Chhanabhai M,Gaulard P,Klapper W,Calaminici M,Sander B,Thorns C,Campo E,Molina T,Lee A,Pfreundschuh M,Horning S,Lister A,Sehn LH,Raemaekers J,Hagenbeek A,Gascoyne RD,Weller E

doi

10.1182/blood-2011-04-345256

subject

Has Abstract

pub_date

2011-06-30 00:00:00

pages

7070-8

issue

26

eissn

0006-4971

issn

1528-0020

pii

blood-2011-04-345256

journal_volume

117

pub_type

杂志文章,随机对照试验

相关文献

BLOOD文献大全
  • Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.

    abstract::In 1981 the BFM group introduced a new treatment strategy for B-cell acute lymphoblastic leukemia (B-ALL). A cytoreductive prephase (prednisone/cyclophosphamide) was followed by eight 5-day courses of chemotherapy. Fractionated cyclophosphamide, methotrexate (MTX) 0.5 g/m2 (24-hour infusion), and MTX intrathecally wer...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Reiter A,Schrappe M,Ludwig WD,Lampert F,Harbott J,Henze G,Niemeyer CM,Gadner H,Müller-Weihrich S,Ritter J

    更新日期:1992-11-15 00:00:00

  • Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS.

    abstract::This study was performed to assess the utility of tumor-derived fragmentary DNA, or circulating tumor DNA (ctDNA), for identifying high-risk patients for relapse of acute myeloid leukemia and myelodysplastic syndrome (AML/MDS) after undergoing myeloablative allogeneic hematopoietic stem cell transplantation (alloSCT)....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-10-880690

    authors: Nakamura S,Yokoyama K,Shimizu E,Yusa N,Kondoh K,Ogawa M,Takei T,Kobayashi A,Ito M,Isobe M,Konuma T,Kato S,Kasajima R,Wada Y,Nagamura-Inoue T,Yamaguchi R,Takahashi S,Imoto S,Miyano S,Tojo A

    更新日期:2019-06-20 00:00:00

  • Post-5-fluorouracil human marrow: stem cell characteristics and renewal properties after autologous marrow transplantation.

    abstract::The effect of 5-fluorouracil (5-FU) pretreatment on human bone marrow (BM) progenitor/stem cells and recovery of hematopoiesis after autologous marrow transplant was studied. Twenty-one patients were treated with 5-FU (15 mg/kg to 45 mg/kg) intravenously (IV) for 1 to 3 days administered 6 to 22 days before BM harvest...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Stewart FM,Temeles D,Lowry P,Thraves T,Grosh WW,Quesenberry PJ

    更新日期:1993-05-01 00:00:00

  • Increased basal and induced tyrosine phosphorylation of the insulin-like growth factor I receptor beta subunit in circulating mononuclear cells of patients with polycythemia vera.

    abstract::We have previously shown that circulating progenitor cells in patients with polycythemia vera (PV) are hypersensitive to insulin-like growth factor I (IGF-I) with respect to erythroid burst formation in serum-free medium, and that this effect occurs through the IGF-I receptor. To investigate the molecular basis of thi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mirza AM,Correa PN,Axelrad AA

    更新日期:1995-08-01 00:00:00

  • FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation.

    abstract::Acute myeloid leukemia (AML) is driven by niche-derived and cell-autonomous stimuli. Although many cell-autonomous disease drivers are known, niche-dependent signaling in the context of the genetic disease heterogeneity has been difficult to investigate. Here, we analyzed the role of Bruton tyrosine kinase (BTK) in AM...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-06-585216

    authors: Oellerich T,Mohr S,Corso J,Beck J,Döbele C,Braun H,Cremer A,Münch S,Wicht J,Oellerich MF,Bug G,Bohnenberger H,Perske C,Schütz E,Urlaub H,Serve H

    更新日期:2015-03-19 00:00:00

  • Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.

    abstract::Gaucher disease, caused by a deficiency of the lysosomal enzyme glucocerebrosidase, leads to prominent glucosylceramide accumulation in lysosomes of tissue macrophages (Gaucher cells). Here we show glucosylsphingosine, the deacylated form of glucosylceramide, to be markedly increased in plasma of symptomatic nonneuron...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-05-352971

    authors: Dekker N,van Dussen L,Hollak CE,Overkleeft H,Scheij S,Ghauharali K,van Breemen MJ,Ferraz MJ,Groener JE,Maas M,Wijburg FA,Speijer D,Tylki-Szymanska A,Mistry PK,Boot RG,Aerts JM

    更新日期:2011-10-20 00:00:00

  • A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.

    abstract::Inherited bleeding, thrombotic, and platelet disorders (BPDs) are diseases that affect ∼300 individuals per million births. With the exception of hemophilia and von Willebrand disease patients, a molecular analysis for patients with a BPD is often unavailable. Many specialized tests are usually required to reach a put...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-12-688267

    authors: Simeoni I,Stephens JC,Hu F,Deevi SV,Megy K,Bariana TK,Lentaigne C,Schulman S,Sivapalaratnam S,Vries MJ,Westbury SK,Greene D,Papadia S,Alessi MC,Attwood AP,Ballmaier M,Baynam G,Bermejo E,Bertoli M,Bray PF,Bury L,

    更新日期:2016-06-09 00:00:00

  • Corticosteroids reversibly inhibit chemotactic peptide-receptor binding and granulocyte response, yet allow desensitization and receptor down-regulation.

    abstract::Inhibition of complement-mediated granulocyte aggregation has recently been proposed as a mechanism of action of high-dose corticosteroids in shock states. Such inhibition may be effected through alteration of receptor function. Methylprednisolone inhibits binding of the synthetic chemotaxin f-methionine-leucine-pheny...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Skubitz KM,Hammerschmidt DE

    更新日期:1986-10-01 00:00:00

  • Detection of a human CFC with a high proliferative potential.

    abstract::Colony forming cells (CFC) with high proliferative potential have been detected in nutrient agar cultures of human bone marrow cells containing recombinant human interleukin-3 (IL-3) and granulocyte macrophage colony stimulating factor (GM-CSF). These CFC were detected by the formation of large colonies with diameters...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: McNiece IK,Stewart FM,Deacon DM,Temeles DS,Zsebo KM,Clark SC,Quesenberry PJ

    更新日期:1989-08-01 00:00:00

  • Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group.

    abstract::In a randomized multicenter study the influence of hydroxyurea versus busulfan on the duration of the chronic phase and on survival of chronic myelogenous leukemia (CML) was determined. In addition cross resistance and adverse reactions of the drugs were analyzed. From July 1983 to January 1991, 441 CML patients were ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Hehlmann R,Heimpel H,Hasford J,Kolb HJ,Pralle H,Hossfeld DK,Queisser W,Löffler H,Heinze B,Georgii A

    更新日期:1993-07-15 00:00:00

  • Circulating antibody to transcobalamin II causing retention of vitamin B12 in the blood.

    abstract::A patient with recurrent pulmonary abscess, weight loss, and alcoholism was found to have extremely high serum vitamin B12 and unsaturated vitamin B12-binding capacity (UBBC) levels. While transcobalamin (TC) II was also increased, most of his UBBC was due to an abnormal binding protein which carried greater than 80% ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Carmel R,Tatsis B,Baril L

    更新日期:1977-06-01 00:00:00

  • Natural killer T-cell autoreactivity leads to a specialized activation state.

    abstract::Natural killer T (NKT) cells are innate-like T cells that recognize specific microbial antigens and also display autoreactivity to self-antigens. The nature of NKT-cell autoreactive activation remains poorly understood. We show here that the mitogen-activated protein kinase (MAPK) pathway is operative during human NKT...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-157529

    authors: Wang X,Chen X,Rodenkirch L,Simonson W,Wernimont S,Ndonye RM,Veerapen N,Gibson D,Howell AR,Besra GS,Painter GF,Huttenlocher A,Gumperz JE

    更新日期:2008-11-15 00:00:00

  • Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.

    abstract::Uncontrolled activation of the complement system against endothelial and blood cells is central to the pathogenesis of atypical hemolytic uremic syndrome (aHUS). aHUS patients frequently carry mutations in the inhibitory complement regulator factor H (FH). Mutations cluster in domains 19 and 20 (FH19-20), which are cr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-11-680009

    authors: Hyvärinen S,Meri S,Jokiranta TS

    更新日期:2016-06-02 00:00:00

  • Mechanism of transcriptional activation of the immediate early gene Egr-1 in response to PIXY321.

    abstract::Studies with the granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin-3 (IL-3) fusion protein, PIXY321, demonstrated enhanced biological activity of this molecule in comparison with GM-CSF or IL-3 alone or in combination. Experiments were performed to study the mechanisms resulting in PIXY321-induced ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mignacca RC,Lee HJ,Kwon EM,Sakamoto KM

    更新日期:1996-08-01 00:00:00

  • Montreal platelet syndrome: a defect in calcium-activated neutral proteinase (calpain).

    abstract::Platelets from patients with Montreal platelet syndrome (MPS) consistently display a defect in the mechanisms that regulate platelet size during shape change and undergo spontaneous aggregation and stir-induced microaggregate formation. We now provide data that the surface glycoprotein composition of MPS platelets is ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Okita JR,Frojmovic MM,Kristopeit S,Wong T,Kunicki TJ

    更新日期:1989-08-01 00:00:00

  • Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells.

    abstract::Pim kinases are involved in B-cell development and are overexpressed in B-cell chronic lymphocytic leukemia (CLL). We hypothesized that Pim kinase inhibition would affect B-cell survival. Identified from a screen of imidazo[1,2-b]pyridazine compounds, SGI-1776 inhibits Pim-1, Pim-2, and Pim-3. Treatment of CLL cells w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-212852

    authors: Chen LS,Redkar S,Bearss D,Wierda WG,Gandhi V

    更新日期:2009-11-05 00:00:00

  • Ssb1 and Ssb2 cooperate to regulate mouse hematopoietic stem and progenitor cells by resolving replicative stress.

    abstract::Hematopoietic stem and progenitor cells (HSPCs) are vulnerable to endogenous damage and defects in DNA repair can limit their function. The 2 single-stranded DNA (ssDNA) binding proteins SSB1 and SSB2 are crucial regulators of the DNA damage response; however, their overlapping roles during normal physiology are incom...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-06-725093

    authors: Shi W,Vu T,Boucher D,Biernacka A,Nde J,Pandita RK,Straube J,Boyle GM,Al-Ejeh F,Nag P,Jeffery J,Harris JL,Bain AL,Grzelak M,Skrzypczak M,Mitra A,Dojer N,Crosetto N,Cloonan N,Becherel OJ,Finnie J,Skaar JR,Walkle

    更新日期:2017-05-04 00:00:00

  • Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP.

    abstract::Immune thrombocytopenias are usually associated with normal or increased numbers of megakaryocytes in the marrow. Therefore, the mechanism(s) responsible for the destruction of circulating platelets may not affect megakaryocytes in the same way. One of the possibilities which could account for the differential effect ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stahl CP,Zucker-Franklin D,McDonald TP

    更新日期:1986-02-01 00:00:00

  • Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection.

    abstract::Rituximab, a monoclonal antibody that targets CD20 on B cells, is now central to the treatment of a variety of malignant and autoimmune disorders. Despite this success, a substantial proportion of B-cell lymphomas are unresponsive or develop resistance, hence more potent anti-CD20 monoclonal antibodies (mAbs) are cont...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-263533

    authors: Beers SA,French RR,Chan HT,Lim SH,Jarrett TC,Vidal RM,Wijayaweera SS,Dixon SV,Kim H,Cox KL,Kerr JP,Johnston DA,Johnson PW,Verbeek JS,Glennie MJ,Cragg MS

    更新日期:2010-06-24 00:00:00

  • Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901.

    abstract::Little is known about the molecular characteristics of alloantigens recognized by alloreactive T cells mediating hematologic stem cell graft rejection. In particular, it has never been shown that such alloantigens can be encoded by HLA-DP beta alleles. Indeed, matching for HLA-DP antigens is generally not considered t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.4.1122

    authors: Fleischhauer K,Zino E,Mazzi B,Sironi E,Servida P,Zappone E,Benazzi E,Bordignon C

    更新日期:2001-08-15 00:00:00

  • Thyroid hormone regulates hematopoiesis via the TR-KLF9 axis.

    abstract::Congenital hypothyroidism (CH) is one of the most prevalent endocrine diseases, for which the underlying mechanisms remain unknown; it is often accompanied by anemia and immunodeficiency in patients. Here, we created a severe CH model together with anemia and T lymphopenia to mimic the clinical features of hypothyroid...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-05-783043

    authors: Zhang Y,Xue Y,Cao C,Huang J,Hong Q,Hai T,Jia Q,Wang X,Qin G,Yao J,Wang X,Zheng Q,Zhang R,Li Y,Luo A,Zhang N,Shi G,Wang Y,Ying H,Liu Z,Wang H,Meng A,Zhou Q,Wei H,Liu F,Zhao J

    更新日期:2017-11-16 00:00:00

  • Functions of idh1 and its mutation in the regulation of developmental hematopoiesis in zebrafish.

    abstract::Isocitrate dehydrogenase 1 mutation (IDH1-R132H) was recently identified in acute myeloid leukemia with normal cytogenetics. The mutant enzyme is thought to convert α-ketoglutarate to the pathogenic 2-hydroxyglutarate (2-HG) that affects DNA methylation via inhibition of ten-eleven translocation 2. However, the role o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-09-601187

    authors: Shi X,He BL,Ma AC,Guo Y,Chi Y,Man CH,Zhang W,Zhang Y,Wen Z,Cheng T,Leung AY

    更新日期:2015-05-07 00:00:00

  • Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation.

    abstract::Severe congenital neutropenia (CN) (Kostmann syndrome) is a hematologic disorder characterized by a maturation arrest of myelopoiesis at the promyelocyte/myelocyte stage of development. This arrest results in severe neutropenia leading to absolute neutrophil counts (ANC) below 0.2 x 10(9)/L associated with severe bact...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Zeidler C,Welte K,Barak Y,Barriga F,Bolyard AA,Boxer L,Cornu G,Cowan MJ,Dale DC,Flood T,Freedman M,Gadner H,Mandel H,O'Reilly RJ,Ramenghi U,Reiter A,Skinner R,Vermylen C,Levine JE

    更新日期:2000-02-15 00:00:00

  • Phase 1 study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody obinutuzumab (GA101) in B-cell lymphoma patients.

    abstract::Whereas the chimeric type I anti-CD20 Ab rituximab has improved outcomes for patients with B-cell malignancies significantly, many patients with non-Hodgkin lymphoma (NHL) remain incurable. Obinutuzumab (GA101) is a glycoengineered, humanized anti-CD20 type II Ab that has demonstrated superior activity against type I ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2012-01-404368

    authors: Salles G,Morschhauser F,Lamy T,Milpied N,Thieblemont C,Tilly H,Bieska G,Asikanius E,Carlile D,Birkett J,Pisa P,Cartron G

    更新日期:2012-05-31 00:00:00

  • Delivery of progenitors to the thymus limits T-lineage reconstitution after bone marrow transplantation.

    abstract::T-cell production depends on the recruitment of hematopoietic progenitors into the thymus. T cells are among the last of the hematopoietic lineages to recover after bone marrow transplantation (BMT), but the reasons for this delay are not well understood. Under normal physiologic conditions, thymic settling is selecti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-324954

    authors: Zlotoff DA,Zhang SL,De Obaldia ME,Hess PR,Todd SP,Logan TD,Bhandoola A

    更新日期:2011-08-18 00:00:00

  • Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells.

    abstract::A novel Hodgkin's disease (HD) derived cell line, L1236, was established from the peripheral blood of a patient with advanced Hodgkin's disease. Analysis of immunoglobulin (Ig) gene rearrangements revealed a biallelic Ig heavy chain and a monoallelic Ig kappa light chain gene rearrangement, pointing to a B-lymphoid or...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wolf J,Kapp U,Bohlen H,Kornacker M,Schoch C,Stahl B,Mücke S,von Kalle C,Fonatsch C,Schaefer HE,Hansmann ML,Diehl V

    更新日期:1996-04-15 00:00:00

  • IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors.

    abstract::Long-living memory stem T cells (T(SCM)) with the ability to self-renew and the plasticity to differentiate into potent effectors could be valuable weapons in adoptive T-cell therapy against cancer. Nonetheless, procedures to specifically target this T-cell population remain elusive. Here, we show that it is possible ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-05-431718

    authors: Cieri N,Camisa B,Cocchiarella F,Forcato M,Oliveira G,Provasi E,Bondanza A,Bordignon C,Peccatori J,Ciceri F,Lupo-Stanghellini MT,Mavilio F,Mondino A,Bicciato S,Recchia A,Bonini C

    更新日期:2013-01-24 00:00:00

  • Platelet αIIbβ3 activation: filling in the pieces.

    abstract::In this issue of Blood, Kasirer-Friede and colleagues show that the adhesion and degranulation promoter protein (ADAP) promotes αIIbβ3 activation by presenting the cytoplasmic proteins talin and kindlin to the β3 cytoplasmic tail. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-02-557355

    authors: Bennett JS

    更新日期:2014-05-15 00:00:00

  • CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma.

    abstract::Primary effusion lymphoma (PEL) is an aggressive subtype of non-Hodgkin lymphoma characterized by short survival with current therapies, emphasizing the urgent need to develop new therapeutic approaches. Brentuximab vedotin (SGN-35) is an anti-CD30 monoclonal antibody (cAC10) conjugated by a protease-cleavable linker ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-481713

    authors: Bhatt S,Ashlock BM,Natkunam Y,Sujoy V,Chapman JR,Ramos JC,Mesri EA,Lossos IS

    更新日期:2013-08-15 00:00:00

  • Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state.

    abstract::This study reassesses the occurrence of Epstein-Barr virus (EBV) diversity and coinfection versus dominance of a single viral strain within immunocompetent normal carriers. Polymerase chain reaction analysis of several different polymorphic loci of the EBV genome was performed on collections of peripheral blood mononu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Srivastava G,Wong KY,Chiang AK,Lam KY,Tao Q

    更新日期:2000-04-01 00:00:00